CN108113893B - Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof - Google Patents
Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof Download PDFInfo
- Publication number
- CN108113893B CN108113893B CN201711458900.0A CN201711458900A CN108113893B CN 108113893 B CN108113893 B CN 108113893B CN 201711458900 A CN201711458900 A CN 201711458900A CN 108113893 B CN108113893 B CN 108113893B
- Authority
- CN
- China
- Prior art keywords
- filling material
- magnesium phosphate
- dental filling
- premixed
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims abstract description 86
- 238000011049 filling Methods 0.000 title claims abstract description 57
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 title claims abstract description 43
- 239000004137 magnesium phosphate Substances 0.000 title claims abstract description 43
- 229910000157 magnesium phosphate Inorganic materials 0.000 title claims abstract description 43
- 229960002261 magnesium phosphate Drugs 0.000 title claims abstract description 43
- 235000010994 magnesium phosphates Nutrition 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000005312 bioglass Substances 0.000 claims abstract description 12
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 10
- 239000000725 suspension Substances 0.000 claims abstract description 10
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 8
- 239000010452 phosphate Substances 0.000 claims abstract description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical class [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 4
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 claims description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 4
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 3
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 claims description 3
- 239000010634 clove oil Substances 0.000 claims description 3
- 235000019837 monoammonium phosphate Nutrition 0.000 claims description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 3
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 229910001936 tantalum oxide Inorganic materials 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 229910001928 zirconium oxide Inorganic materials 0.000 claims description 3
- 239000010775 animal oil Substances 0.000 claims description 2
- 239000003125 aqueous solvent Substances 0.000 claims description 2
- 229910000416 bismuth oxide Inorganic materials 0.000 claims description 2
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- -1 phosphate compound Chemical class 0.000 claims description 2
- 229920002545 silicone oil Polymers 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 239000012530 fluid Substances 0.000 abstract description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract description 5
- 238000001356 surgical procedure Methods 0.000 abstract description 3
- 239000008346 aqueous phase Substances 0.000 abstract description 2
- 210000004262 dental pulp cavity Anatomy 0.000 abstract description 2
- 239000012071 phase Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 239000004568 cement Substances 0.000 description 10
- 239000001506 calcium phosphate Substances 0.000 description 6
- 229960001714 calcium phosphate Drugs 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 6
- 235000012241 calcium silicate Nutrition 0.000 description 6
- 229910052918 calcium silicate Inorganic materials 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- 239000011521 glass Substances 0.000 description 5
- 238000006703 hydration reaction Methods 0.000 description 5
- 239000000378 calcium silicate Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000007711 solidification Methods 0.000 description 4
- 230000008023 solidification Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000011398 Portland cement Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000002639 bone cement Substances 0.000 description 2
- JHLNERQLKQQLRZ-UHFFFAOYSA-N calcium silicate Chemical compound [Ca+2].[Ca+2].[O-][Si]([O-])([O-])[O-] JHLNERQLKQQLRZ-UHFFFAOYSA-N 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- BCAARMUWIRURQS-UHFFFAOYSA-N dicalcium;oxocalcium;silicate Chemical compound [Ca+2].[Ca+2].[Ca]=O.[O-][Si]([O-])([O-])[O-] BCAARMUWIRURQS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000002631 root canal filling material Substances 0.000 description 2
- 235000019976 tricalcium silicate Nutrition 0.000 description 2
- 229910021534 tricalcium silicate Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WMWLMWRWZQELOS-UHFFFAOYSA-N bismuth(III) oxide Inorganic materials O=[Bi]O[Bi]=O WMWLMWRWZQELOS-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000805 composite resin Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000011396 hydraulic cement Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/836—Glass
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dental Preparations (AREA)
Abstract
The invention discloses a suspension-stable premixed magnesium phosphate-based dental filling material and a preparation method and application thereof. The filling material of the invention takes magnesium oxide and at least one phosphate as main phases, at least one water-miscible non-aqueous phase solvent and at least one jet-retarding material to prepare the dental filling material with excellent injectability, wherein the filling material can also comprise at least one bioglass. The material can keep fluid under sealed condition, and can be hydrated, solidified and hardened after being filled into teeth and contacting with physiological body fluid. The invention utilizes the excellent biocompatibility and bioactivity of the magnesium phosphate-based material to prepare the premixed magnesium phosphate-based dental filling material with stable suspension, and the premixed magnesium phosphate-based dental filling material can be used as a filling material in the fields of capping marrow surgery, root canal therapy, dental restoration and the like.
Description
Technical Field
The invention relates to a dental filling material and a preparation method and application thereof, in particular to a premixed magnesium phosphate-based dental filling material with stable suspension and a preparation method and application thereof. The invention belongs to the technical field of medical materials.
Background
Dental filling materials have found wide application in dental clinics. It can be classified into a dental cement filling material, a dental prosthetic filling material and a dental filling material for protection according to functions. The development of dental filling materials has undergone a long process, and many materials such as clove oil zinc oxide, zinc phosphate, silver amalgam, glass cement composite resin, etc. are used as dental filling materials. An ideal dental filling material must have good biocompatibility, antibacterial properties and clinical handling properties. In addition, biological activity is used as a measure of the bonding performance of the material to the tooth, and therefore, biological cement or biological glass materials are also receiving increasing attention from dentists and researchers.
The calcium silicate material most used in the dental filling material is a trioxide Material (MTA). Mahmoud torabenejad first disclosed in 1998 a method of repairing a tooth cavity with MTA material (U.S. patent No. 5,769,638). The main components of the MTA material are tricalcium silicate and dicalcium silicate, and the MTA material is similar to Portland cement, can be used in a root canal filling material, but is troublesome to prepare and causes waste. Chinese patent "premixed biological hydraulic cement paste composition and its application" (patent No. CN200880011743.1) discloses a premixed cement paste for medical or dental use, which is prepared by premixing tricalcium silicate, dicalcium silicate and an organic solvent, and is convenient for a doctor to use, but the setting time is too long, some of them require 72 hours to set, and the too long setting time not only results in prolonged waiting time of a patient, but also makes the surgical procedure more complicated. The portland cement does not contain phosphorus element, can not form hydroxyapatite, and has biocompatibility inferior to phosphate with dentin.
Chinese patent 'injectable efficient suspension stable calcium phosphate cement and preparation method and application thereof' (patent No. CN200910197934.8) discloses an injectable calcium phosphate cement material system, which improves the suspension stability of a calcium phosphate cement premix system by adding fumed silica and modified products thereof. The defects are that the calcium phosphate cement has insufficient strength and is easy to break.
Therefore, the further development of the dental filling material with short coagulation time, high biological activity, sufficient compressive strength and good clinical operation performance has very important significance.
Magnesium Phosphate Cement (MPC) is mainly prepared by sintered magnesium oxide, dihydric phosphate and a retarder according to a certain proportion, and has the characteristics of quick setting and high early strength. MPC is similar to Calcium Phosphate Cement (CPC) and can be self-solidified under the physiological environment of human body, and the hydration product is phosphate. Many years of research show that MPC has good biocompatibility and is an ideal bone defect repair material, but MPC has two problems of too fast hydration reaction speed and great hydration heat release, so that MPC has not been paid enough attention and research for a long time. Such problems have not been well solved, as MPC has reached a maximum hydration temperature of approximately 70 ℃ under adiabatic conditions. Patent CN102807335A proposes a method for synthesizing magnesium phosphate bone cement by self-coating controlled hydration reaction, namely, a method for pre-reacting magnesium oxide surface with a small amount of potassium dihydrogen phosphate is adopted, the setting time of magnesium phosphate bone cement is prolonged from 0.7-4 minutes before coating to 6-17 minutes after coating, and the peak value of exothermic temperature is reduced from 55.1-70.5 ℃ to 32.6-38.3 ℃, thus having certain beneficial effect. The invention pre-mixes solid phase components such as magnesium oxide and the like with the organic solvent, similarly solves the 2 problems caused by the over-high reaction speed, the condensation time reaches 3 to 15 hours, and the peak value of the exothermic temperature is basically consistent with the ambient temperature without increasing.
The filling material of the invention takes magnesium oxide and at least one phosphate as main phases, at least one water-miscible non-aqueous phase solvent and at least one jet-retarding material to prepare the dental filling material with excellent injectability, wherein the filling material can also comprise at least one bioglass. The material can keep fluid under sealed condition, and can be hydrated, solidified and hardened after being filled into teeth and contacting with physiological body fluid. The invention utilizes the excellent biocompatibility and bioactivity of the magnesium phosphate-based material to prepare the premixed magnesium phosphate-based dental filling material with stable suspension, and the premixed magnesium phosphate-based dental filling material can be used as a filling material in the fields of capping marrow surgery, root canal therapy, dental restoration and the like.
Disclosure of Invention
The invention aims to provide a premixed magnesium phosphate-based dental filling material which has short coagulation time, high bioactivity and good clinical operability.
In order to achieve the purpose, the invention adopts the following technical means:
the invention relates to a suspension-stable premixed magnesium phosphate-based dental filling material, which comprises the following components: (a) magnesium oxide; (b) at least one phosphate compound; (c) a bioglass; (d) at least one radiation-blocking material; and (e) at least one water-miscible, non-aqueous solvent;
in the premixed magnesium phosphate base dental filling material, the solid components (a), (b), (c) and (d) account for 40 to 92 percent of the total mass of the premixed magnesium phosphate base dental filling material, and the liquid component (e) accounts for 8 to 60 percent of the total mass of the premixed material with stable suspension;
wherein, in the solid components, the components (a) and (b) account for 10-89% of the total mass of the premixed magnesium phosphate-based dental filling material, and the mass ratio of the components (a) and (b) is as follows: (0.05-3): 1;
the component (c) accounts for 0 to 50 percent of the total mass of the premixed magnesium phosphate-based dental filling material;
the component (d) accounts for 10 to 40 percent of the total mass of the premixed magnesium phosphate based dental filling material.
Among them, preferably, component (b) is selected from: at least one of potassium dihydrogen phosphate, sodium dihydrogen phosphate, ammonium dihydrogen phosphate, calcium dihydrogen phosphate, magnesium phosphate, and hydroxyapatite.
Among them, preferably, component (c) is selected from: at least one of bioglass 45S, bioglass 58S, and bioglass 63S.
Among them, preferably, component (d) is selected from: at least one of zirconium oxide, bismuth oxide and tantalum oxide.
Among them, preferably, component (e) is selected from: glycerin, propylene glycol, ethylene glycol, polyethylene glycol, silicone oil, clove oil, animal oil, and vegetable oil.
Furthermore, the invention also provides the application of the premixed magnesium phosphate-based dental filling material in the preparation of filling materials for dental treatment.
Compared with the prior art, the invention has the advantages that:
(1) compared with calcium phosphate cement, the premixed magnesium phosphate-based dental filling material has long solidification time, is convenient for a doctor to operate, and has unobvious reaction temperature rise;
(2) compared with the premixed calcium silicate dental filling material, the premixed magnesium phosphate based dental filling material has the following advantages:
(A) the solidification is fast;
(B) the phosphate has better biocompatibility than silicate, and forms hydroxyapatite;
(C) the compressive strength is adjustable, and different requirements are met by adjusting the proportion of the magnesium phosphate and the bioglass; if the strength of the calcium silicate paste is adjusted to 30-40MA for root canal filling materials, the calcium silicate paste has lower strength and can be well used for retreatment; such as, for example, hard-tuning, may be used for repair,
drawings
FIG. 1 is a photograph of a sample obtained in example 2.
FIG. 2 is a photomicrograph of the material obtained in example 2 after water hardening.
Detailed Description
The invention will be further described with reference to specific embodiments, and the advantages and features of the invention will become apparent as the description proceeds. The examples are illustrative only and do not limit the scope of the present invention in any way. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention, and that such changes and modifications may be made without departing from the spirit and scope of the invention.
Example 1 preparation of suspension-stabilized premixed magnesium phosphate-based dental filling Material 1
(1) Weighing the following raw materials in percentage by weight: (a) heavy-burned magnesia of 21 percent; (b) 23% of monopotassium phosphate; (c) 37% of zirconium oxide and (d) 19% of polyethylene glycol;
(2) sequentially putting the components in the step (1) into a glass container, mechanically mixing by using a stainless steel stirring rod, and fully blending for 5 min;
(3) and then transferring the mixed paste into a medical injector with an injection hose needle to obtain the premixed magnesium phosphate-based dental filling material with stable suspension.
The material keeps fluid under the sealing condition, is extruded and sampled to be placed in a constant temperature and humidity box (or filled to the teeth to contact with physiological body fluid) with the humidity of more than 95 percent at the temperature of 37 ℃, is hydrated, solidified and hardened, and has the following setting time: for 5 hours.
EXAMPLE 2 preparation of suspension-Stable premixed magnesium phosphate-based dental filling Material 2
(1) Weighing the following raw materials in percentage by weight: (a) 9% of light-burned magnesium oxide; (b) 12% of sodium dihydrogen phosphate; (c) 63S 10% of bioglass; (d) 15% of anhydrous calcium dihydrogen phosphate; and (e) tantalum oxide 33% (f) polyethylene glycol 21%;
(2) sequentially putting the components in the step (1) into a glass container, mechanically mixing by using a stainless steel stirring rod, and fully blending for 5 min;
(3) and then transferring the mixed paste into a medical injector with an injection hose needle to obtain the premixed magnesium phosphate-based dental filling material with stable suspension.
FIG. 1 is a photograph of a sample obtained in example 2. The material keeps fluid under the sealing condition, is extruded and sampled to be placed in a constant temperature and humidity box with the temperature of 37 ℃ and the humidity of more than 95% (or is filled to the condition that teeth are contacted with physiological body fluid), is hydrated, solidified and hardened, and has the following solidification time: for 13 hours. FIG. 2 is a photomicrograph of the material obtained after water has been cured in example 2.
EXAMPLE 3 preparation of suspension-Stable premixed magnesium phosphate-based dental filling Material 3
(1) Weighing the following raw materials in percentage by weight: (a) 7% of dead burned magnesium oxide; (b) 7% of ammonium dihydrogen phosphate; (c) 20% of calcium dihydrogen phosphate; (d) 35% of bismuth trioxide and 31% of (e) glycerol.
(2) Sequentially putting the components in the step (1) into a glass container, mechanically mixing by using a stainless steel stirring rod, and fully blending for 5 min;
(3) and then transferring the mixed paste into a medical injector with an injection hose needle to obtain the premixed magnesium phosphate-based dental filling material with stable suspension.
The material keeps fluid under the sealing condition, is extruded and sampled to be placed in a constant temperature and humidity box with the temperature of 37 ℃ and the humidity of more than 95% (or is filled to the condition that teeth are contacted with physiological body fluid), is hydrated, solidified and hardened, and has the following solidification time: for 15 hours.
Claims (6)
1. A suspension-stable premixed magnesium phosphate-based dental filling material, characterized in that it comprises the following components: (a) magnesium oxide; (b) at least one phosphate compound; (c) a bioglass; (d) at least one radiation-blocking material; and (e) at least one water-miscible, non-aqueous solvent; the suspension-stable premixed magnesium phosphate-based dental filling material does not contain calcium silicate compounds;
in the premixed magnesium phosphate base dental filling material, the solid components (a), (b), (c) and (d) account for 40 to 92 percent of the total mass of the premixed magnesium phosphate base dental filling material, and the liquid component (e) accounts for 19 to 31 percent of the total mass of the premixed material with stable suspension;
wherein, in the solid components, the components (a) and (b) account for 34 to 44 percent of the total mass of the premixed magnesium phosphate-based dental filling material, and the mass ratio of the components (a) to (b) is as follows: (0.05-3): 1;
the component (c) accounts for 0 to 10 percent of the total mass of the premixed magnesium phosphate-based dental filling material;
the component (d) accounts for 33 to 37 percent of the total mass of the premixed magnesium phosphate-based dental filling material;
the sum of the mass percentages of the components is 100 percent;
wherein component (e) is selected from: at least one of glycerol, propylene glycol, ethylene glycol, polyethylene glycol, silicone oil, animal oil, and vegetable oil.
2. The suspension-stable premixed magnesium phosphate-based dental filling material according to claim 1, wherein component (b) is selected from the group consisting of: at least one of potassium dihydrogen phosphate, sodium dihydrogen phosphate, calcium dihydrogen phosphate, ammonium dihydrogen phosphate, and hydroxyapatite.
3. The suspension-stable premixed magnesium phosphate-based dental filling material according to claim 1, wherein component (c) is selected from the group consisting of: at least one of bioglass 45S, bioglass 58S, and bioglass 63S.
4. The suspension-stable premixed magnesium phosphate-based dental filling material according to claim 1, wherein component (d) is selected from the group consisting of: at least one of zirconium oxide, bismuth oxide and tantalum oxide.
5. The suspension-stable, premixed magnesium phosphate-based dental filling material according to claim 1, wherein the vegetable oil comprises clove oil.
6. Use of a premixed magnesium phosphate based dental filling material according to any of claims 1 to 5 for the preparation of a filling material for dental treatment.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711458900.0A CN108113893B (en) | 2017-12-28 | 2017-12-28 | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof |
| PCT/CN2018/000215 WO2019127612A1 (en) | 2017-12-28 | 2018-06-06 | Stably suspended premixed magnesium- phosphate-based dental filling material, preparation method therefor and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711458900.0A CN108113893B (en) | 2017-12-28 | 2017-12-28 | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108113893A CN108113893A (en) | 2018-06-05 |
| CN108113893B true CN108113893B (en) | 2020-02-14 |
Family
ID=62232157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711458900.0A Active CN108113893B (en) | 2017-12-28 | 2017-12-28 | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN108113893B (en) |
| WO (1) | WO2019127612A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108113893B (en) * | 2017-12-28 | 2020-02-14 | 吴秉民 | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof |
| CN111888521B (en) * | 2020-06-11 | 2021-12-17 | 上海禾麦医学科技有限公司 | Bone repair material and preparation method thereof |
| CN116492230B (en) * | 2023-05-25 | 2024-12-20 | 武汉理工大学 | Storable and injectable tooth root canal filling material and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103283A (en) * | 1993-06-24 | 1995-06-07 | 丹茨普利股份有限公司 | Dental prosthesis |
| CN1691929A (en) * | 2002-10-24 | 2005-11-02 | 彭特恩临床科技有限公司 | Dental filling material |
| CN102807335A (en) * | 2012-07-13 | 2012-12-05 | 西安理工大学 | Method for synthesizing magnesium phosphate biological bone cement through self-covering controlled hydration reaction |
| CN107080697A (en) * | 2017-03-31 | 2017-08-22 | 烟台正海生物科技股份有限公司 | A kind of suspending stabilized premixing calcium silicates base canal filling material and preparation method and application |
| CN107411976A (en) * | 2017-03-31 | 2017-12-01 | 烟台正海生物科技股份有限公司 | Compound self-curing root canal filling material of the calcium silicates of a kind of premixing/magnesium phosphate two-phase and preparation method and application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2365091B1 (en) * | 2010-03-12 | 2013-01-24 | Universitat Politècnica De Catalunya | AN INORGANIC CEMENT FOR BIOMEDICAL APPLICATIONS, PROCEDURE FOR THE PREPARATION AND USE OF SUCH CEMENT. |
| CN108113893B (en) * | 2017-12-28 | 2020-02-14 | 吴秉民 | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof |
-
2017
- 2017-12-28 CN CN201711458900.0A patent/CN108113893B/en active Active
-
2018
- 2018-06-06 WO PCT/CN2018/000215 patent/WO2019127612A1/en active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103283A (en) * | 1993-06-24 | 1995-06-07 | 丹茨普利股份有限公司 | Dental prosthesis |
| CN1691929A (en) * | 2002-10-24 | 2005-11-02 | 彭特恩临床科技有限公司 | Dental filling material |
| CN102807335A (en) * | 2012-07-13 | 2012-12-05 | 西安理工大学 | Method for synthesizing magnesium phosphate biological bone cement through self-covering controlled hydration reaction |
| CN107080697A (en) * | 2017-03-31 | 2017-08-22 | 烟台正海生物科技股份有限公司 | A kind of suspending stabilized premixing calcium silicates base canal filling material and preparation method and application |
| CN107411976A (en) * | 2017-03-31 | 2017-12-01 | 烟台正海生物科技股份有限公司 | Compound self-curing root canal filling material of the calcium silicates of a kind of premixing/magnesium phosphate two-phase and preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108113893A (en) | 2018-06-05 |
| WO2019127612A1 (en) | 2019-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2395910C (en) | Bioactive and osteoporotic bone cement | |
| Chow et al. | A natural bone cement—A laboratory novelty led to the development of revolutionary new biomaterials | |
| US10052402B2 (en) | Injectable, biodegradable bone cements and methods of making and using same | |
| CN107334645B (en) | Water-cured temperature-sensitive injection type dental root canal repairing material and application thereof | |
| CN108113893B (en) | Suspension-stable premixed magnesium phosphate-based dental filling material and preparation method and application thereof | |
| RU2407552C2 (en) | Injectable composite applicable as bone filler | |
| CN108721693B (en) | Premixed strontium silicate based biological hydraulic cement paste composition, preparation method and application thereof | |
| CN109395160B (en) | Rapidly degradable injectable bone cement and application thereof | |
| US20130156864A1 (en) | Inorganic Cement for Biomedical uses, Preparation Method Thereof and Use of Same | |
| CN101428152A (en) | Composite self-curing material of dicalcium silicate, preparation and uses thereof | |
| JP3965249B2 (en) | Calcium phosphate cement and calcium phosphate cement composition | |
| JPH0248479A (en) | Method for curing curable composition | |
| CN106031799A (en) | Calcium silicate/strontium salt bone cement and preparation method thereof | |
| Aquino et al. | Preparation and characterization of cement-based hydroxyapatite and galactomannan extracted from Adenanthera pavonina L. seeds | |
| JPH0793941B2 (en) | Manufacturing method of biological hard tissue repair material | |
| JP4319280B2 (en) | Calcium phosphate cement powder and calcium phosphate cement composition | |
| WO1990008530A1 (en) | Root canal filling material comprising hardenable paste | |
| JPH07114804B2 (en) | Medical curable composition | |
| JP2002291866A (en) | Calcium phosphate cement powder and calcium phosphate cement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200612 Address after: 101300 301, building 10, yard 12, Juyuan Middle Road, Mapo Town, Shunyi District, Beijing Patentee after: BEIJING SAIRUTE ORAL CAVITY MEDICAL INSTRUMENT Co.,Ltd. Address before: 300102 Tianjin Nankai District wide open four road style spring garden 25 Building 1 door 301. Patentee before: Wu Bingmin |